Information Journal Paper
APA:
Copy. (2020). The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer. PLOS ONE, 15(7), 0-0. SID. https://sid.ir/paper/1100178/en
Vancouver:
Copy. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer. PLOS ONE[Internet]. 2020;15(7):0-0. Available from: https://sid.ir/paper/1100178/en
IEEE:
Copy, “The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer,” PLOS ONE, vol. 15, no. 7, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1100178/en